SEI Investments’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.3M Buy
351,146
+69,673
+25% +$15.6M 0.07% 287
2025
Q4
$60M Buy
281,473
+76,154
+37% +$15.7M 0.06% 341
2025
Q3
$40.8M Sell
205,319
-31,251
-13% -$5.83M 0.04% 441
2025
Q2
$40.8M Sell
236,570
-21,443
-8% -$3.49M 0.05% 412
2025
Q1
$40.2M Sell
258,013
-5,569
-2% -$796K 0.05% 388
2024
Q4
$36.3M Sell
263,582
-10,165
-4% -$1.34M 0.05% 423
2024
Q3
$40.9M Buy
273,747
+9,176
+3% +$1.24M 0.05% 381
2024
Q2
$36.1M Sell
264,571
-81,615
-24% -$11.1M 0.05% 382
2024
Q1
$52.3M Sell
346,186
-15,644
-4% -$2.23M 0.08% 279
2023
Q4
$45.6M Sell
361,830
-34,610
-9% -$3.45M 0.07% 297
2023
Q3
$37.1M Sell
396,440
-13,944
-3% -$1.3M 0.07% 310
2023
Q2
$36.6M Sell
410,384
-65,637
-14% -$5.71M 0.06% 324
2023
Q1
$51M Buy
476,021
+38,770
+9% +$4.44M 0.09% 222
2022
Q4
$53.4M Sell
437,251
-36,268
-8% -$4.21M 0.12% 176
2022
Q3
$48.9M Buy
473,519
+21,718
+5% +$2.06M 0.11% 190
2022
Q2
$42M Buy
451,801
+7,242
+2% +$683K 0.09% 233
2022
Q1
$52.2M Buy
444,559
+21,868
+5% +$2.53M 0.1% 192
2021
Q4
$56.9M Buy
422,691
+33,468
+9% +$4.98M 0.11% 198
2021
Q3
$62M Buy
389,223
+90,902
+30% +$12.4M 0.13% 161
2021
Q2
$39.2M Buy
298,321
+35,929
+14% +$4.79M 0.09% 231
2021
Q1
$33.8M Buy
262,392
+19,290
+8% +$2.93M 0.09% 232
2020
Q4
$40.6M Buy
243,102
+8,328
+4% +$1.38M 0.1% 186
2020
Q3
$36.2M Buy
234,774
+84,122
+56% +$12.1M 0.1% 172
2020
Q2
$22.3M Buy
150,652
+64,466
+75% +$8.85M 0.07% 279
2020
Q1
$9.71M Buy
86,186
+20,278
+31% +$2.63M 0.04% 483
2019
Q4
$9.17M Buy
65,908
+899
+1% +$99.9K 0.03% 619
2019
Q3
$6.26M Buy
65,009
+20,938
+48% +$2.34M 0.02% 828
2019
Q2
$5.08M Buy
44,071
+18,971
+76% +$2.27M 0.02% 924
2019
Q1
$2.95M Buy
+25,100
New +$2.2M 0.01% 1150

Other funds holding ASND